Ribosome Inactivating Proteins from Plants Inhibiting Viruses

Overview

Journal Virol Sin

Specialty Microbiology

Date 2011 Dec 14

PMID 22160935

Citations 12

Authors

Inderdeep Kaur

R C Gupta

Munish Puri

Affiliations

Soon will be listed here.

Abstract

Many plants contain ribosome inactivating proteins (RIPs) with N-glycosidase activity, which depurinate large ribosomal RNA and arrest protein synthesis. RIPs so far tested inhibit replication of mRNA as well as DNA viruses and these proteins, isolated from plants, are found to be effective against a broad range of viruses such as human immunodeficiency virus (HIV), hepatitis B virus (HBV) and herpes simplex virus (HSV). Most of the research work related to RIPs has been focused on antiviral activity against HIV; however, the exact mechanism of antiviral activity is still not clear. The mechanism of antiviral activity was thought to follow inactivation of the host cell ribosome, leading to inhibition of viral protein translation and host cell death. Enzymatic activity of RIPs is not limited to depurination of the large rRNA, in addition they can depurinate viral DNA as well as RNA. Recently, Phase I/II clinical trials have demonstrated the potential use of RIPs for treating patients with HIV disease. The aim of this review is to focus on various RIPs from plants associated with anti-HIV activity.

Citing Articles

Submerged leaves of live indoor foliage plants adsorb H1N1 influenza virus from suspension.

Song H, Yang S, Jo J, Choi Y, Lee I, Lee B Plant Signal Behav. 2023; 18(1):2163869.

PMID: 36635991 PMC: 9851199. DOI: 10.1080/15592324.2022.2163869.

Antiviral peptides from aquatic organisms: Functionality and potential inhibitory effect on SARS-CoV-2.

Sumon T, Hussain M, Hasan M, Rashid A, Abualreesh M, Jang W Aquaculture. 2021; 541:736783.

PMID: 33883784 PMC: 8049179. DOI: 10.1016/j.aquaculture.2021.736783.

Antiviral Activity of Ribosome-Inactivating Proteins.

Citores L, Iglesias R, Ferreras J Toxins (Basel). 2021; 13(2).

PMID: 33499086 PMC: 7912582. DOI: 10.3390/toxins13020080.

Alpha-momorcharin enhances Nicotiana benthamiana resistance to tobacco mosaic virus infection through modulation of reactive oxygen species.

Zhu F, Zhu P, Xu F, Che Y, Ma Y, Ji Z Mol Plant Pathol. 2020; 21(9):1212-1226.

PMID: 32713165 PMC: 7411664. DOI: 10.1111/mpp.12974.

The Roles of Alpha-Momorcharin and Jasmonic Acid in Modulating the Response of to .

Yang T, Meng Y, Chen L, Lin H, Xi D Front Microbiol. 2016; 7:1796.

PMID: 27881976 PMC: 5101195. DOI: 10.3389/fmicb.2016.01796.

References

Barbieri L, Ferreras J, Barraco A, Ricci P, Stirpe F . Some ribosome-inactivating proteins depurinate ribosomal RNA at multiple sites. Biochem J. 1992; 286 ( Pt 1):1-4. PMC: 1133008. DOI: 10.1042/bj2860001. View

Peumans W, Hao Q, Van Damme E . Ribosome-inactivating proteins from plants: more than RNA N-glycosidases?. FASEB J. 2001; 15(9):1493-506. DOI: 10.1096/fj.00-0751rev. View

Zhao W, Feng D, Sun S, Han T, Sui S . The anti-viral protein of trichosanthin penetrates into human immunodeficiency virus type 1. Acta Biochim Biophys Sin (Shanghai). 2010; 42(2):91-7. DOI: 10.1093/abbs/gmp111. View

Huang P, Sun Y, Chen H, Kung H, Lee-Huang S . Proteolytic fragments of anti-HIV and anti-tumor proteins MAP30 and GAP31 are biologically active. Biochem Biophys Res Commun. 1999; 262(3):615-23. DOI: 10.1006/bbrc.1999.1213. View

Zarling J, Moran P, Haffar O, Sias J, Richman D, Spina C . Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies. Nature. 1990; 347(6288):92-5. DOI: 10.1038/347092a0. View

Uckun F, Rajamohan F, Pendergrass S, Ozer Z, Waurzyniak B, Mao C . Structure-based design and engineering of a nontoxic recombinant pokeweed antiviral protein with potent anti-human immunodeficiency virus activity. Antimicrob Agents Chemother. 2003; 47(3):1052-61. PMC: 149289. DOI: 10.1128/AAC.47.3.1052-1061.2003. View

Puri M . "Momordica balsamina: a medicinal and neutraceutical plant for health care management". Comments: biotechnological potential of M. balsamina revealed. Curr Pharm Biotechnol. 2010; 11(2):229. DOI: 10.2174/138920110790909696. View

Wang J, Nie H, Tam S, Huang H, Zheng Y . Anti-HIV-1 property of trichosanthin correlates with its ribosome inactivating activity. FEBS Lett. 2002; 531(2):295-8. DOI: 10.1016/s0014-5793(02)03539-1. View

Taylor G, Matsuoka M . Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene. 2005; 24(39):6047-57. DOI: 10.1038/sj.onc.1208979. View

10.

Uckun F, Bellomy K, ONeill K, Messinger Y, Johnson T, Chen C . Toxicity, biological activity, and pharmacokinetics of TXU (anti-CD7)-pokeweed antiviral protein in chimpanzees and adult patients infected with human immunodeficiency virus. J Pharmacol Exp Ther. 1999; 291(3):1301-7. View

11.

Rajamohan F, Venkatachalam T, Irvin J, Uckun F . Pokeweed antiviral protein isoforms PAP-I, PAP-II, and PAP-III depurinate RNA of human immunodeficiency virus (HIV)-1. Biochem Biophys Res Commun. 1999; 260(2):453-8. DOI: 10.1006/bbrc.1999.0922. View

12.

Huang H, Chan H, Wang Y, Ouyang D, Zheng Y, Tam S . Trichosanthin suppresses the elevation of p38 MAPK, and Bcl-2 induced by HSV-1 infection in Vero cells. Life Sci. 2006; 79(13):1287-92. DOI: 10.1016/j.lfs.2006.03.047. View

13.

Lee-Huang S, Huang P, Bourinbaiar A, Chen H, Kung H . Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. Proc Natl Acad Sci U S A. 1995; 92(19):8818-22. PMC: 41058. DOI: 10.1073/pnas.92.19.8818. View

14.

Byers V, Levin A, Waites L, Starrett B, Mayer R, CLEGG J . A phase I/II study of trichosanthin treatment of HIV disease. AIDS. 1990; 4(12):1189-96. DOI: 10.1097/00002030-199012000-00002. View

15.

Uckun F, Chelstrom L, Dibirdik I, Irvin J, Langlie M, Myers D . TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus. Antimicrob Agents Chemother. 1998; 42(2):383-8. PMC: 105418. DOI: 10.1128/AAC.42.2.383. View

16.

Stirpe F, Battelli M . Ribosome-inactivating proteins: progress and problems. Cell Mol Life Sci. 2006; 63(16):1850-66. PMC: 11136412. DOI: 10.1007/s00018-006-6078-7. View

17.

Sawasaki T, Morishita R, Ozawa A, Ogasawara T, Madin K, Endo Y . Mechanism of ribosome RNA apurinic site specific lyase. Nucleic Acids Symp Ser. 2000; (42):257-8. DOI: 10.1093/nass/42.1.257. View

18.

Lee-Huang S, Nara P, Chen H, Kung H, Huang P, Huang H . MAP 30: a new inhibitor of HIV-1 infection and replication. FEBS Lett. 1990; 272(1-2):12-8. DOI: 10.1016/0014-5793(90)80438-o. View

19.

Puri M, Kaur I, Kanwar R, Gupta R, Chauhan A, Kanwar J . Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy. Curr Mol Med. 2009; 9(9):1080-94. DOI: 10.2174/156652409789839071. View

20.

Stirpe F . Ribosome-inactivating proteins. Toxicon. 2004; 44(4):371-83. DOI: 10.1016/j.toxicon.2004.05.004. View